Arm's Bold 2031 Revenue Projection Fuels After-Hours Rally, But DeepValue Report Urges Caution on Near-Term Execution

What happened

Arm Holdings' stock surged 6% in after-hours trading after CEO Rene Haas projected $25 billion in revenue for 2031 from a new chip, signaling ambitious long-term growth targets. This optimism contrasts with the DeepValue report's WAIT rating, which notes Arm's current high valuation at P/E 166x and EV/EBITDA 145x, with royalties up 27% YoY but still anchored in a mobile segment facing a 2026 handset contraction forecast of -2.1% YoY. The report emphasizes that near-term catalysts, such as ACV growth at +28% YoY and declining RPO at -8% YoY, require validation to support the bull case of server CPU expansion and CSS adoption. Skepticism is warranted, as such distant projections often mask immediate risks like licensing volatility, PRC export controls, and customer concentration, which could derail growth before 2031. Investors should view this news as a promotional boost rather than a fundamental shift, with the stock's sensitivity to quarterly license optics remaining a critical overhang.

Implication

The projection reinforces Arm's long-term growth narrative, potentially aligning with the bull scenario of server CPU share expansion and higher-value CSS monetization. However, it fails to address current vulnerabilities, such as declining RPO that tightens visibility and persistent handset market headwinds pressuring 46% of royalty revenue. Investors must remain cautious, as the stock's historical volatility stems from sensitivity to licensing misses, and any deviation from upcoming Q4 FY26 guidance could trigger sharp derisking. The projection's feasibility hinges on successful mix shift to data-center and AI-adjacent products, which lacks concrete evidence in royalty streams amid export-control constraints. Therefore, while the news may support speculative optimism, it doesn't alter the need for disciplined monitoring of ACV and royalty trends over the next 3-6 months.

Thesis delta

No material shift in the investment thesis is justified; the projection is aspirational and doesn't change the near-term catalysts or valuation overhang. The DeepValue report's WAIT rating remains appropriate, as the next two quarters must still validate royalty resilience above +20% YoY and ACV stability ≥+20% YoY to warrant a re-rating. Investors should treat this as noise unless it translates into improved licensing momentum or RPO stabilization in upcoming disclosures.